Back to Market Feed

REYVOW 50 MG TABLET

lasmiditan
$88.7339per EA
DEA Schedule CV

Strength

50 mg/1

NDC

00002431208

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

12/17/2025

Active Ingredients

LASMIDITAN

Approval Type

New Drug (NDA)

FDA Application

NDA211280

On Market Since

10/11/2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-0.0%

1Y

+0.1%

3Y

-0.0%

5Y

N/A

All

+10.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.